{
  "id": "949ec008c8b5d771",
  "title": "STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy",
  "description": "FDA officials are advising drug developers to study the long-term effects of using CAR-T in autoimmune conditions out of concern the therapies could carry risks.",
  "content": "FDA officials are advising drug developers to study the long-term effects of using CAR-T in autoimmune conditions out of concern the therapies could carry risks.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/02/fda-long-term-follow-up-studies-car-t-therapy-automimmune-disorders/?utm_campaign=rss",
  "published_at": "2026-02-02T22:00:35+00:00",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy",
    "description": "FDA officials are advising drug developers to study the long-term effects of using CAR-T in autoimmune conditions out of concern the therapies could carry risks.",
    "url": "https://www.statnews.com/2026/02/02/fda-long-term-follow-up-studies-car-t-therapy-automimmune-disorders/?utm_campaign=rss",
    "published": "2026-02-02T22:00:35+00:00",
    "source": "STAT"
  }
}